Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

No innocent bystanders: pertussis vaccination and evolutionary parallelisms between Bordetella parapertussis and Bordetella pertussis

  • Bouchez, Valérie
  • Landier, Annie
  • Armatys, Nathalie
  • Guillot, Sophie
  • Moreno-Mingorance, Albert
  • Mir-Cros, Alba
  • Martin Gomez, M. Teresa
  • González-López, Juan José
Bordetella parapertussis; Phylogenetic diversity; Vaccine driven evolution, Bordetella parapertussis; Diversidad filogenética; Evolución impulsada por vacunas, Bordetella parapertussis; Diversitat filogenètica; Evolució impulsada per vacunes, Pathogens adapting to the human host and to vaccination-induced immunity may follow parallel evolutionary paths. Bordetella parapertussis (Bpp) contributes significantly to the burden of whooping cough (pertussis) and shares vaccine antigens with Bordetella pertussis (Bp); both pathogens are phylogenetically related and ecological competitors. Bp vaccine antigen-coding genes have accumulated variation, including pertactin (PRN) disruptions, after the introduction of acellular vaccines in the 1990s. We aimed to evaluate evolutionary parallelisms in Bpp, even though pertussis vaccines were designed against Bp. We sequenced 242 Bpp isolates collected in France, the USA and Spain between 1937 and 2019, spanning pre-vaccine and two vaccines eras. We investigated the temporal evolution of Bpp sublineages using a Bayesian approach based on whole-genome SNPs and performed comparative genomic analyses focusing on antigen and virulence gene loci. The most recent common ancestor of all sequenced Bpp isolates was estimated around the year 1877, making it one of the youngest human pathogens, and the Bpp evolutionary rate we estimated (2.12×10−7 substitutions per site per year) was remarkably similar to the one previously reported for Bp (2.24×10−7). PRN antigen deficiency in Bpp was driven by 18 disruptive mutations, including deletion prn:ΔG-1895 estimated to have occurred around 1998 and observed in 73.8 % (149/202) of post-2007 Bpp isolates. In addition, we detected two early (year ~1900) mutations in the bvgA-fhaB intergenic region, which controls multiple virulence factors including the filamentous haemagglutinin antigen. Gene clusters for pertussis toxin and fimbriae showed a surprising lack of gene decay. Our findings suggest early adaptation of Bpp to humans through modulation of the bvgAS regulon, and a rapid adaptation through the loss of PRN expression, representing a late evolutionary parallelism concomitant with acellular vaccination against whooping cough., The French National Reference Center for Whooping Cough and Other Bordetella Infections receives support from Institut Pasteur and Public Health France (Santé publique France, Saint Maurice, France). This work was supported financially by the French Government’s Investissement d’Avenir grants Laboratoire d’Excellence Integrative Biology of Emerging Infectious Diseases (ANR-10-LABX-62-IBEID) and INCEPTION (ANR-16-CONV-0005) and by the Spanish ‘Ministerio de Economía y Competitividad’ and ‘Instituto de Salud Carlos III’ [grant number FIS PI18/00703], and by the Centro de Investigación Biomédica en Red (CIBER de Enfermedades Infecciosas [grant number CB21/13/00054]). This work was also supported by the CDC’s Advanced Molecular Detection (AMD) programme.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Population dynamics and antigenic drift of Bordetella pertussis following whole cell vaccine replacement, Barcelona, Spain, 1986–2015

  • Mir Cros, Alba
  • Moreno Mingorance, Albert
  • Martin Gomez, M Teresa
  • Codina Grau, Gema
  • Cornejo Sánchez, Thais
  • Rajadell Guiu, Mireia
  • Rodrigo Gonzalo de Liria, Carlos
  • Pumarola Suñé, Tomàs
  • Fàbrega Santamaría, Anna
  • Gonzalez Lopez, Juan Jose
  • Campins Martí, Magda
MLVA; PFGE; Vacuna contra la tos ferina, MLVA; PFGE, Vacuna contra la tos ferina, MLVA; PFGE; Pertussis vaccine, Among the factors associated with the resurgence of whooping cough, special emphasis has been given to pathogen adaptation after the introduction of the acellular vaccine (ACV). To assess the impact of the vaccine transition strategy from whole-cell vaccine (WCV) to ACV on population dynamics of Bordetella pertussis in Barcelona (Spain), we studied 339 isolates collected from 1986 to 2015 by PFGE and multi-locus variable-number tandem repeat analysis (MLVA). Additionally, allelic variants for the pertussis toxin and its promoter, pertactin, type 3 fimbriae and fimbrial serotyping were assessed to determine its antigenic drift. A shift was observed in the B. pertussis population as well as in its antigenic profile concurrently with the introduction of ACV in Barcelona. Four out of the five most prevalent PFGE profiles were replaced by new profiles following the ACV introduction. MLVA type 27 was the dominant genotype, and its frequency increased from 25% to 79.3% after WCV replacement. Antigen typing demonstrated the emergence of prn2, ptxP3, fim3-2 and a shift from the fimbriae 3 to the fimbriae 2 serotypes after the ACV introduction. Our findings support the presence of population and antigenic dynamic changes in B. pertussis likely driven by the introduction of ACV., This work was supported by the “Ministerio de Economía y Competitividad”, “Instituto de Salud Carlos III”, and cofinanced by the European Regional Development Fun (ERDF) “A Way to Achieve Europe” (Spanish Network for Research in Infectious Diseases [grant number RD16/0016/0003], “Fondo de Investigación Sanitaria [grant number FIS PI18/ 00703]). AMC is supported by the “Agència de Gestió d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya” [grant number 2018FI_B_00855].
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Population dynamics and antigenic drift of Bordetella pertussis following whole cell vaccine replacement, Barcelona, Spain, 1986-2015

  • Mir-Cros, Alba|||0000-0003-4827-9824
  • Moreno Mingorance, Albert|||0000-0002-3073-5046
  • Martin-Gomez, M. Teresa|||0000-0001-8119-8749
  • Codina, María Gema|||0000-0002-5313-5086
  • Cornejo-Sánchez, Thais|||0000-0002-1350-0413
  • Rajadell Guiu, Mireia
  • van Esso, Diego
  • Rodrigo Gonzalo de Líria, Carlos|||0000-0003-1140-2585
  • Campins Martí, Magda|||0000-0002-8841-6195
  • Jané i Checa, Mireia|||0000-0002-1302-6723
  • Pumarola Suñé, Tomàs|||0000-0002-5171-7461
  • Fàbrega-Santamaria, Anna|||0000-0002-3866-2291
  • González-López, Juanjo|||0000-0003-2419-5909
Among the factors associated with the resurgence of whooping cough, special emphasis has been given to pathogen adaptation after the introduction of the acellular vaccine (ACV). To assess the impact of the vaccine transition strategy from whole-cell vaccine (WCV) to ACV on population dynamics of Bordetella pertussis in Barcelona (Spain), we studied 339 isolates collected from 1986 to 2015 by PFGE and multi-locus variable-number tandem repeat analysis (MLVA). Additionally, allelic variants for the pertussis toxin and its promoter, pertactin, type 3 fimbriae and fimbrial serotyping were assessed to determine its antigenic drift. A shift was observed in the B. pertussis population as well as in its antigenic profile concurrently with the introduction of ACV in Barcelona. Four out of the five most prevalent PFGE profiles were replaced by new profiles following the ACV introduction. MLVA type 27 was the dominant genotype, and its frequency increased from 25% to 79.3% after WCV replacement. Antigen typing demonstrated the emergence of prn2, ptxP3, fim3-2 and a shift from the fimbriae 3 to the fimbriae 2 serotypes after the ACV introduction. Our findings support the presence of population and antigenic dynamic changes in B. pertussis likely driven by the introduction of ACV.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

No innocent bystanders: pertussis vaccination and evolutionary parallelisms between Bordetella parapertussis and Bordetella pertussis

  • Bouchez, Valérie
  • Landier, Annie
  • Armatys, Nathalie
  • Guillot, Sophie
  • Moreno-Mingorance, Albert
  • Mir-Cros, Alba
  • Martin Gomez, M. Teresa
  • González-López, Juan José
Bordetella parapertussis; Phylogenetic diversity; Vaccine driven evolution, Bordetella parapertussis; Diversidad filogenética; Evolución impulsada por vacunas, Bordetella parapertussis; Diversitat filogenètica; Evolució impulsada per vacunes, Pathogens adapting to the human host and to vaccination-induced immunity may follow parallel evolutionary paths. Bordetella parapertussis (Bpp) contributes significantly to the burden of whooping cough (pertussis) and shares vaccine antigens with Bordetella pertussis (Bp); both pathogens are phylogenetically related and ecological competitors. Bp vaccine antigen-coding genes have accumulated variation, including pertactin (PRN) disruptions, after the introduction of acellular vaccines in the 1990s. We aimed to evaluate evolutionary parallelisms in Bpp, even though pertussis vaccines were designed against Bp. We sequenced 242 Bpp isolates collected in France, the USA and Spain between 1937 and 2019, spanning pre-vaccine and two vaccines eras. We investigated the temporal evolution of Bpp sublineages using a Bayesian approach based on whole-genome SNPs and performed comparative genomic analyses focusing on antigen and virulence gene loci. The most recent common ancestor of all sequenced Bpp isolates was estimated around the year 1877, making it one of the youngest human pathogens, and the Bpp evolutionary rate we estimated (2.12×10−7 substitutions per site per year) was remarkably similar to the one previously reported for Bp (2.24×10−7). PRN antigen deficiency in Bpp was driven by 18 disruptive mutations, including deletion prn:ΔG-1895 estimated to have occurred around 1998 and observed in 73.8 % (149/202) of post-2007 Bpp isolates. In addition, we detected two early (year ~1900) mutations in the bvgA-fhaB intergenic region, which controls multiple virulence factors including the filamentous haemagglutinin antigen. Gene clusters for pertussis toxin and fimbriae showed a surprising lack of gene decay. Our findings suggest early adaptation of Bpp to humans through modulation of the bvgAS regulon, and a rapid adaptation through the loss of PRN expression, representing a late evolutionary parallelism concomitant with acellular vaccination against whooping cough., The French National Reference Center for Whooping Cough and Other Bordetella Infections receives support from Institut Pasteur and Public Health France (Santé publique France, Saint Maurice, France). This work was supported financially by the French Government’s Investissement d’Avenir grants Laboratoire d’Excellence Integrative Biology of Emerging Infectious Diseases (ANR-10-LABX-62-IBEID) and INCEPTION (ANR-16-CONV-0005) and by the Spanish ‘Ministerio de Economía y Competitividad’ and ‘Instituto de Salud Carlos III’ [grant number FIS PI18/00703], and by the Centro de Investigación Biomédica en Red (CIBER de Enfermedades Infecciosas [grant number CB21/13/00054]). This work was also supported by the CDC’s Advanced Molecular Detection (AMD) programme.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Population dynamics and antigenic drift of Bordetella pertussis following whole cell vaccine replacement, Barcelona, Spain, 1986–2015

  • Mir Cros, Alba
  • Moreno Mingorance, Albert
  • Martin Gomez, M Teresa
  • Codina Grau, Gema
  • Cornejo Sánchez, Thais
  • Rajadell Guiu, Mireia
  • Rodrigo Gonzalo de Liria, Carlos
  • Pumarola Suñé, Tomàs
  • Fàbrega Santamaría, Anna
  • Gonzalez Lopez, Juan Jose
  • Campins Martí, Magda
MLVA; PFGE; Vacuna contra la tos ferina, MLVA; PFGE, Vacuna contra la tos ferina, MLVA; PFGE; Pertussis vaccine, Among the factors associated with the resurgence of whooping cough, special emphasis has been given to pathogen adaptation after the introduction of the acellular vaccine (ACV). To assess the impact of the vaccine transition strategy from whole-cell vaccine (WCV) to ACV on population dynamics of Bordetella pertussis in Barcelona (Spain), we studied 339 isolates collected from 1986 to 2015 by PFGE and multi-locus variable-number tandem repeat analysis (MLVA). Additionally, allelic variants for the pertussis toxin and its promoter, pertactin, type 3 fimbriae and fimbrial serotyping were assessed to determine its antigenic drift. A shift was observed in the B. pertussis population as well as in its antigenic profile concurrently with the introduction of ACV in Barcelona. Four out of the five most prevalent PFGE profiles were replaced by new profiles following the ACV introduction. MLVA type 27 was the dominant genotype, and its frequency increased from 25% to 79.3% after WCV replacement. Antigen typing demonstrated the emergence of prn2, ptxP3, fim3-2 and a shift from the fimbriae 3 to the fimbriae 2 serotypes after the ACV introduction. Our findings support the presence of population and antigenic dynamic changes in B. pertussis likely driven by the introduction of ACV., This work was supported by the “Ministerio de Economía y Competitividad”, “Instituto de Salud Carlos III”, and cofinanced by the European Regional Development Fun (ERDF) “A Way to Achieve Europe” (Spanish Network for Research in Infectious Diseases [grant number RD16/0016/0003], “Fondo de Investigación Sanitaria [grant number FIS PI18/ 00703]). AMC is supported by the “Agència de Gestió d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya” [grant number 2018FI_B_00855].